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Abstract
Pleural plaques are considered as a markers of asbestos exposure and not as an independent risk factor for the development of asbestos-related neoplastic diseases. 
However isolated studies showed an association between pleural plaques and malignat pleural mesothelioma. A clinical case of a patient with an history of occupational 
asbestos exposure affected by asbestosis, pleural plaques and pleural mesothelioma is presented.
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Introduction
Pleural plaques (PPs) represent the most common non malignant 
asbestos-related disease (ARDs). Currently PPs are widely referred as a 
marker of asbestos exposure and not as an independent risk factor for 
the development of asbestos-related neoplastic diseases, in particular 
with regard to lung cancer [1]. However, the association between PPs 
and pleural mesothelioma (PM) remains controversial, as isolated 
studies showed a relationship between PPs and PM [2].
A clinical case of a patient with a history of occupational asbestos 
exposure affected by asbestosis and PPs is presented. During the 
follow up managed by the Occupational Medicine of Siena a PM was 
diagnosed at a PP.
Case presentation
82-year-old male worker in follow-up since 1998 for asbestosis and 
PPs. The patient worked at a geothermal station from 1960 to 1994. 
His work consisted in maintenance and repair of the industrial plant 
that implicated insulation removal before repairing and insulation 
of pipelines with asbestos. First hospitalization occurred in 1998 
with the diagnosis of asbestosis and PPs. The mineralogical analysis 
of bronchoalveolar lavage fluid (BALF) with transmission electron 
microscopy (TEM) demonstrated an asbestos fibres concentration of 
622 ff/mL BALF and 466 ff/mL BALF for amphibole and chrysotile 
respectively. A previous chest high-resolution computed tomography 
(HRCT) in 2013 showed a slight progression of the well known PPs. 
In March 2017, as the patient complained chest pain, dry cough and 
acute dyspnoea, another chest HRCT was performed demonstrating 
pleural effusion and wide thickening of the visceral pleura in which was 
possible appreciate areas of thickening. The histological examination 
carried out on pleural biopsies concluded for pattern consistent with 
desmoplastic mesothelioma on sclero-hyalin plaques. The case was 
discussed at the Multidisciplinary Oncology Group to evaluate the 
possible radiotherapy treatment.
Discussion
Although some studies on cohorts of asbestos exposed workers have 
shown correlation between PPs and PM [3], it is likely that this was the 
result of several factors including intensity and duration of exposure. 
Therefore PPs per se do not seem an independent risk factor for the 
development of neoplastic pleuropulmonary diseases [1]. Despite 
this, scientific literature is poor. Research has been focused on the 
relationship between PPs and lung cancer, while there is a lack of studies 
on the possible relationship between PPs and the development of PM. 
Actually the differentiation of PPs from early stages of PM is difficult, 
due to several overlapping radiological features [4,5]. Kato et al. [6] 
studied differences in the level and localization of pleural irregularities 
in early PM and benign asbestos pleural effusion using CT. They 
demonstrated that the level and localization of pleural irregularities 
significantly differed between patients with benign asbestos pleural 
effusion and PM. In this sense fluorodeoxyglucose PET/CT has been 
shown to be a useful diagnostic tool for differentiate PM from benign 
PPs [7]. Probably these difficulties have affected research in the specific 
field. In the reported case the intensity of exposure was demonstrated 
by the presence of asbestosis and the fibers concentration in BALF. This 
represents in itself a powerful risk factor for PM.
Conclusion
The widespread belief that there is no relationship between PPs and 
PM is not supported by a vast literature as it happens for the absence 
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of association between PPs and lung cancer. In the patient described 
it is not possible to determine whether the localization of the PM at a 
PP is incidental or not and whether the PM can be attributed only to 
intense exposure or even to the presence of PPs. Similar cases may not 
be uncommon even if not reported in the literature.
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